Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

(NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced a significant ...

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

and patients with advanced liver cancer and cirrhosis are normally considered unsuitable for surgery or transplant. In a new study published in the British Journal of Surgery, researchers describe ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Innovative therapies and surgical techniques have the potential to transform liver cancer care. People with cirrhosis—a ...

At a three-day event, hepatology experts focused on improving patient outcomes, particularly in ICU care, while exploring ...

IntroductionHepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It arises from ...

St. David’s Medical Center in Austin is the first hospital in Central Texas to offer histotripsy, a noninvasive ultrasound ...

A new treatment for colorectal cancer that has spread to the liver is showing promising results in Dutch medical trials. The ...